Browse treatments

… scheduled for digital colposcopy and concurrent treatment with thermal ablation or large loop excision of the transformation zone.Results Of th…

…ns typically observed in people living with HIV who discontinue antiretroviral therapy. Therefore, a correct evaluation of patient’s habits and medica…

…ervical cancer shows limited and often short-lived benefit from programmed cell death protein 1 blockade, currently the only approved immunotherapy for this disease. Th…

…Organ transplantation profoundly enhances survival and quality of life for patients w…

…ood collection and individuals with end-stage renal disease, on renal replacement therapy or with active malignancies. Postdischarge survivors were follo…

…or non-binary, and were pursuing (n=19) or had undergone (n=16) masculinising chest surgery.Results Three major themes emerged: chest appearance, health-re…

…Background Chimeric antigen receptor (CAR) T-cell therapy is a promising immunotherapy for patients with refractory or re…

…r insight into consumption routes, frequency, material sharing, opioid agonist treatment, and homelessness—critical factors for understanding vulnerabil…

…ppression. Accelerated aging, persistent immune activation, and antiretroviral therapy exposure contribute to reduced bone mineral density (BMD); howe…

…w rate of HBVr in HBcAb positive hematologic patients receiving immunosuppressive therapy. Despite guideline preferences for newer antivirals, 3TC appear…

…not be eradicated even with suppressive antiretroviral therapy (ART) because it persists in infected cells as a stable integrated g…

…ir (DTG) represent the cornerstone of antiretroviral treatment (ART). Our study aimed to investigate the durability of bictegravir/…